Advances of antibody-drug conjugates in the treatment of metastatic triple-negative breast cancer

Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 6

Abstract

Triple-negative breast cancer (TNBC) is insensitive to endocrine therapy or anti-human epidermal growth factor receptor(HER)-2 targeted therapy due to its lack of expression of hormone receptors and HER-2. Antibody-drug conjugates(ADCs) recognize specific antigens on the surface of cancer cells through specific antibodies, form antigen-antibody complexes that are then internalized, and subsequently release their payloads to kill cancer cells, which offering a novel therapeutic option for metastatic TNBC. Currently, ADCs undergoing research and clinical application in metastatic TNBC include sacituzumab govitecan, datopotamab deruxtecan (Dato-DXd), SKB264, and trastuzumab deruxtecan (T-DXd). This article summarized the targets and structural characteristics of ADCs in metastatic TNBC, systematically reviewed the efficacy and safety of ADCs from relevant clinical studies, and discussed the issues of the clinical application of ADCs.

Authors and Affiliations

Yiwei TONG, Xiaosong CHEN

Keywords

Related Articles

Current status of minimally invasive surgery of gastroesophageal reflux disease

Gastroesophageal reflux disease (GERD) is one of the common gastrointestinal diseases. The treatment options for GERD includes lifestyle changes, medication, and surgery. With the development of surgical technology, mini...

Recent advances in subtyping of biliary tract carcinoma

Biliary tract carcinoma exhibits high heterogeneity at the genomic, epigenetic, and molecular expression levels. The patients even with the same pathological morphology and clinical stage of biliary tract malignant tumor...

Treatment strategies for subacute lower extremities deep vein thrombosis

In this article we primarily explored the treatment strategies for subacute lower extremity deep vein thrombosis (LEDVT). We introduced the definition, incidence, and clinical stage of DVT, emphasized the pathological ch...

Laparoscopic radical resection of hilar cholangiocarcinoma: current status and considerations

Laparoscopic radical resection of hilar cholangiocarcinoma was complex because of the tumor near to hepatic hilum. The resection of hilar cholangiocarcinoma increased in recent years in large medical centers with safety...

Download PDF file
  • EP ID EP761815
  • DOI 10.16139/j.1007-9610.2024.06.13
  • Views 16
  • Downloads 0

How To Cite

Yiwei TONG, Xiaosong CHEN (2024). Advances of antibody-drug conjugates in the treatment of metastatic triple-negative breast cancer. Journal of Surgery : Concepts & Practice, 29(6), -. https://www.europub.co.uk/articles/-A-761815